Back to search
Bladder Urothelial Carcinoma In Situ
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Bladder Urothelial Carcinoma In Situ trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Bladder Urothelial Carcinoma In Situ trials you may qualify forThe goal of this clinical trial is to learn whether a combination of two chemotherapy drugs, Gemcitabine and Docetaxel, can treat high-grade non-muscle-invasive…
This is a phase II, open-label, single-arm, multi-center Study conducted in Canada and the United States. Patients with Non-Muscle Invasive Bladder Cancer ("NMI…
This research study is creating a way to collect and store specimens and information from participants who may be at an increased risk of developing cancer, or…
A database has been created and will be used in which data will be collected in electronic format relating to adult patients who underwent one of the following…
This phase II trial studies the effect of adding pembrolizumab to gemcitabine in treating patients with non-muscle invasive bladder cancer whose cancer does not…
The goal of this clinical trial is to learn if TARA-002 can treat high-grade non-muscle invasive bladder cancer (NMIBC) in BCG-naïve adults 18 years of age or o…